Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
<p>Abstract</p> <p>Background</p> <p>Aberrant ErbB receptor signaling is associated with various types of malignancies. γ-Tocotrienol is a member of the vitamin E family of compounds that displays potent anticancer activity that is associated with suppression in ErbB re...
Main Authors: | Sylvester Paul W, Wali Vikram B, Bachawal Sunitha V |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/84 |
Similar Items
-
Predicting Tumor Responses to Gefitinib and Erlotinib.
Published: (2005-01-01) -
Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
by: Abhita Malaviya, et al.
Published: (2014-01-01) -
Correction: Predicting Tumor Responses to Gefitinib and Erlotinib.
Published: (2012-03-01) -
The antiproliferative effect of γ-tocotrienol and its molecularmechanism (s) of action in 3T3-L1 adipocytes
by: Guang-Yu Huang, et al.
Published: (2011) -
The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
by: Al-Keilani MS, et al.
Published: (2018-10-01)